Distinguished in Ventricular Tachycardia

Daniel Steven

Kerpener Str. 62, 
Koeln, NW, DE 
Distinguished in Ventricular Tachycardia
Kerpener Str. 62, 
Koeln, NW, DE 
OverviewLocationsClinical Research

Overview

Daniel Steven practices in Koeln, Germany. Mr. Steven is rated as a Distinguished expert by MediFind in the treatment of Ventricular Tachycardia. His top areas of expertise are Atrial Fibrillation, Arrhythmias, Ventricular Tachycardia, Cardiac Ablation, and Pacemaker Implantation.

His clinical research consists of co-authoring 196 peer reviewed articles and participating in 9 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 30 articles in the study of Ventricular Tachycardia.

Gender
Male

Locations

Kerpener Str. 62, Koeln, NW 50937, Germany
Other Locations
Kerpener Street 62, Koeln, NW 50937, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

The Optimal Anticoagulation for Enhanced Risk Patients Post-Catheter Ablation for Atrial Fibrillation Trial
The Optimal Anticoagulation for Enhanced Risk Patients Post-Catheter Ablation for Atrial Fibrillation Trial
Enrollment Status: Completed
Publish Date: October 06, 2025
Intervention Type: Drug
Study Drugs: Rivaroxaban, Acetylsalicylic acid
Study Phase: Phase 4
The FARAPULSE FARA-Freedom Trial A Prospective Open Label Single Arm Post Market Clinical Follow-Up Trial of the FARAPULSE Pulsed Field Ablation System in Patients With Paroxysmal Atrial Fibrillation
The FARAPULSE FARA-Freedom Trial A Prospective Open Label Single Arm Post Market Clinical Follow-Up Trial of the FARAPULSE Pulsed Field Ablation System in Patients With Paroxysmal Atrial Fibrillation
Enrollment Status: Completed
Publish Date: October 17, 2024
Intervention Type: Device
Study Phase: Not Applicable
Supervised Obesity Reduction Trial for AF Ablation Patients
Supervised Obesity Reduction Trial for AF Ablation Patients
Enrollment Status: Completed
Publish Date: September 19, 2022
Intervention Type: Procedure
Study Phase: Not Applicable
Utilizing Novel Dipole Density Capabilities to Objectively Visualize the Etiology of Recurrent Atrial Fibrillation Following a Failed AF Ablation (RECOVER AF)
Utilizing Novel Dipole Density Capabilities to Objectively Visualize the Etiology of Recurrent Atrial Fibrillation Following a Failed AF Ablation (RECOVER AF)
Enrollment Status: Completed
Publish Date: July 27, 2022
Intervention Type: Device
Study Phase: Not Applicable
Cardiac Resynchronisation Therapy and AV Nodal Ablation Trial in Atrial Fibrillation
Cardiac Resynchronisation Therapy and AV Nodal Ablation Trial in Atrial Fibrillation
Enrollment Status: Completed
Publish Date: November 13, 2020
Intervention Type: Procedure, Drug
Study Phase: Not Applicable
Cardiac Contractility Modulation (CCM) Therapy in Subjects With Medically Refractory Heart Failure: A Randomized Efficacy Study
Cardiac Contractility Modulation (CCM) Therapy in Subjects With Medically Refractory Heart Failure: A Randomized Efficacy Study
Enrollment Status: Terminated
Publish Date: September 02, 2020
Intervention Type: Drug, Device
Study Phase: Not Applicable
Utilizing Novel Dipole Density Capabilities to Objectively Visualize the Etiology of Rhythms in Atrial Fibrillation (UNCOVER-AF)
Utilizing Novel Dipole Density Capabilities to Objectively Visualize the Etiology of Rhythms in Atrial Fibrillation (UNCOVER-AF)
Enrollment Status: Completed
Publish Date: June 05, 2020
Intervention Type: Device
Study Phase: Not Applicable
CAPA-VU Trial Catheter Ablation in Paroxymal Atrial Fibrillation Based on UNIVU
CAPA-VU Trial Catheter Ablation in Paroxymal Atrial Fibrillation Based on UNIVU
Enrollment Status: Completed
Publish Date: April 30, 2019
Intervention Type: Procedure
Study Phase: Not Applicable
Randomized Controlled Trial Comparing Internal vs External Cardioversion in ICD Patients
Randomized Controlled Trial Comparing Internal vs External Cardioversion in ICD Patients
Enrollment Status: Completed
Publish Date: January 26, 2018
Intervention Type: Device
Study Phase: Not Applicable
View 8 Less Clinical Trials

196 Total Publications

Transforming Atrial Fibrillation Management by Targeting Comorbidities and Reducing Atrial Fibrillation Burden: the 10th AFNET/EHRA Consensus Conference.
Transforming Atrial Fibrillation Management by Targeting Comorbidities and Reducing Atrial Fibrillation Burden: the 10th AFNET/EHRA Consensus Conference.
Journal: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
Published: November 28, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Steven's expertise for a condition
ConditionClose
View All 29 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile